Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 4.50M | $ 7.80M | $ 6.00M | $ 6.00M | $ 13.60M |
Total Assets | $ 284.00M | $ 318.20M | $ 238.50M | $ 204.70M | $ 184.10M |
Total Debt | $ 63.60M | $ 81.80M | $ 53.50M | $ 49.30M | $ 45.90M |
Net Debt | $ 59.10M | $ 74.00M | $ 47.50M | $ 43.30M | $ 32.30M |
Total Liabilities | $ 242.50M | $ 279.70M | $ 201.70M | $ 177.10M | $ 156.10M |
Stockholders Equity | $ 41.50M | $ 38.50M | $ 36.80M | $ 27.60M | $ 28.00M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |